Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Dermata Therapeutics, Inc. (DRMA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Dermata Therapeutics, Inc. (DRMA), most recent 12 months reported: net loss $8.37M. Latest balance sheet on file: liquid cash $4.41M. From SEC filings. Others in Pharmaceutical Preparations: CYPHERPUNK TECHNOLOGIES INC. · Decoy Therapeutics Inc. · DiaMedica Therapeutics Inc. · DAMORA THERAPEUTICS, INC. · Design Therapeutics, Inc. · Dogwood Therapeutics, Inc. · Dyne Therapeutics, Inc. · EDESA BIOTECH, INC.

Stock screener

Watchlist